Xiao-Li Yu
Overview
Explore the profile of Xiao-Li Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lin W, Wang C, Jiao Z, Yu X, Zhang J, Zhang W, et al.
Ther Drug Monit
. 2019 Apr;
41(5):665-673.
PMID: 31033858
Background: Oxcarbazepine (OXC) is almost completely metabolized to its10-monohydroxy derivative (MHD), which is responsible for the pharmacological effects of the drug. Several studies have described the population pharmacokinetics (PPK) of...
12.
Bai S, Wang Q, Yu X, Chen T, Yang J, Shi J, et al.
RSC Adv
. 2018 Jul;
8(11):5797-5805.
PMID: 29963303
Neural stem cells (NSCs) exhibit preferential homing toward some types of brain lesion, but their migratory property during radiation brain injury (RBI) remains unexplored. Here, we use the superparamagnetic iron...
13.
Zhou Z, Yang Z, Yu X, Guo X
Cancer Med
. 2018 Jun;
7(7):3110-3117.
PMID: 29856131
In the past, searching for effective radiotherapy sensitization molecular targets and improving the radiation sensitivity of malignant tumors was the hot topic for the oncologists, but with little achievements. We...
14.
Yu X, Yang J, Chen T, Liu Y, Xue W, Wang M, et al.
Can J Gastroenterol Hepatol
. 2018 Apr;
2018:6075207.
PMID: 29623265
Background: The prognostic values of weight loss and body mass index (BMI) in esophageal carcinoma remain controversial. This study aimed to evaluate the impacts of weight loss on the survival...
15.
Zhou Z, Wang C, Sun X, Yang Z, Chen X, Shao Z, et al.
Cancer Med
. 2018 Feb;
7(4):1030-1042.
PMID: 29479819
The aim of this study was to explore the independent prognostic factors related to postoperative recurrence-free survival (RFS) in patients with breast phyllodes tumors (PTBs). A retrospective analysis was conducted...
16.
Jiao L, Zhang J, Chen L, Yu X, Han Y, Yang F, et al.
Transfus Apher Sci
. 2017 Nov;
56(6):855-857.
PMID: 29102288
Objective: To study serologic and gene characteristics of the B(A) blood group of blood donation volunteers in Jilin Province, China. Methods: ABO subgroups were identified by standard serologic techniques in...
17.
Yao J, Yu X, Zhang F, Zhang W, Zhou G, Tang L, et al.
Chin J Cancer
. 2017 Mar;
36(1):26.
PMID: 28264724
Background: In the era of intensity-modulated radiotherapy (IMRT), the role of neoadjuvant chemotherapy (NACT) in treating ascending-type nasopharyngeal carcinoma (NPC) is under-evaluated. This study was to compare the efficacy of...
18.
Jiao L, Yu J, Yu X, Chen L, Han Y, Yang F
Transfus Apher Sci
. 2017 Feb;
56(2):223-225.
PMID: 28153706
Objective: To identify the precise ABO blood type subgroups with genotyping. Method: We screened ABO blood type from voluntary blood donors in our blood collection center. Samples were first examined...
19.
Zhou Z, Yang Z, Yu X, Guo X
J Thorac Dis
. 2017 Jan;
8(11):3427-3430.
PMID: 28066623
Postoperative radiotherapy plays an important role in the multidisciplinary treatment of breast cancer. However, it remains a controversy whether it is necessary to carry out prophylactic internal mammary nodes irradiation...
20.
Zhou Z, Wang C, Yang Z, Yu X, Guo X
J Thorac Dis
. 2017 Jan;
8(11):3361-3368.
PMID: 28066617
Phyllodes tumors of the breast are rare tumor types that consist of 0.3-1.0% in all breast tumors. The naming and classification of breast phyllodes tumor have been debated for years....